DoW Military Burn, Technology/Therapeutic Development Award

The DoW Military Burn, Technology/Therapeutic Development Award, is a funding opportunity from the Department of Defense, Department of the Army -- USAMRAA. The award aims to support the translation of promising preclinical findings into burn products for clinical application in an austere, resource-limited, distributed operational environment. The technology or therapeutic product(s) to be developed must be product-oriented, such as medical devices, drugs, or clinical practice guidelines, and address one or more of the FY26 MBRP TTDA focus areas. The award has a maximum period of performance of 3 years, and the Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $5M to fund approximately three TTDA applications/proposals. Key elements of the award include impact, relevance to military health, preliminary data, and technology readiness. • Development and/or validation of methods to triage, treat, and/or prevent complications of cold injury • Research to innovate best practices in the acute burn care continuum in a combat setting • Development and/or validation of methods for use in a combat setting to prevent, assess, and/or treat burn injury-related complications • Interventions applied during the early, acute phase of burn injury that prevent or mitigate later development of chronic pain, neuropathy, pruritus, and temperature dysregulation